Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid

Journal of Clinical Investigation

Volumn 108, Issue 8, 2001, Pages 1151-1158

  Chen, R ^a   Ning, G ^a   Zhao, M L ^a   Fleming, M G ^a   Diaz, L A ^a   Werb, Z ^a   Liu, Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN G; MYELOPEROXIDASE; RECOMBINANT INTERLEUKIN 8;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEMIDESMOSOME; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEWBORN; NONHUMAN; PEMPHIGOID; PRIORITY JOURNAL; SKIN DISEASE;

EID: 0034773439     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11494     Document Type: Article

References (53)

1. Bullous pemphigoid
2. Pemphigus
3. Eosinophilic spongiosis in pemphigus. A report of an unusual histological change in pemphigus
4. Eosinophilic spongiosis in bullous pemphigoid
5. Experimental bullous pemphigoid in guinea pigs: The role of pemphigoid antibodies, complement, and migrating cells
6. Mononuclear cell infiltrates in bullous disease
7. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid
8. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement
9. Bullous pemphigoid, an ultrastructural study of the inflammatory response: Eosinophil, basophil and mast granule changes in multiple biopsies from one patient
10. An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients
11. High histamine level in the blister fluid of bullous pemphigoid
12. Herpes gestationis: Clinical and histological features of twenty-eight cases
13. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180
14. The role of complement in experimental bullous pemphigoid
15. A major role for neutrophils in experimental bullous pemphigoid
16. d mice: Their value for the analysis of the roles of mast cells in biological responses in vivo
17. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
18. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody
19. Recruitment of neutrophils during IgE-dependent cutaneous late phase responses in the mouse is mast cell dependent: Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha
20. Disodium cromoglycate activity in three in vitro models of the immediate hypersensitivity reaction in lung
21. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein
22. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid
23. 1251-Fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells
24. IL-4 inhibits mouse mast cell FCE RI expression through a STAT6-dependent mechanism
25. Molecular organization of the complement system
26. Bullous pemphigoid: Eosinophil, neutrophil and mast cell degranulation in lesional tissue
27. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins
28. The analysis of mast cell function in vivo using mast cell deficient-mice
29. Cytokine production by mast cells and basophils
30. New concepts about the mast cell
31. Increased levels of immunoreactive leukotriene B4 in blister fluids of bullous pemphigoid patients and effects of a selective 5-lipoxygenase inhibitor on experimental skin lesions
32. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid
33. Cell-mediated immune reaction in the mechanism of blister formation in bullous pemphigoid
34. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid
35. Cytokine profile of patients with bullous pemphigoid
36. The interleukin-2 receptor in lesions and serum of bullous pemphigoid
37. Neutrophil elastase plays a critical role in experimental bullous pemphigoid
38. Mast cells and matrix degradation at sites of tumor invasion in rat mammary adenocarcinomas
39. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
40. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis
41. Critical protective role of mast cells in a model of acute septic peritonitis
42. Mast cell modulation of neutrophils influx and bacterial clearance at sites of infection through TNF-α
43. Impaired mast cell-dependent natural immunity in complement C3-deficient mice
44. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: Selective enhancement of eosinophil recruitment by histamine
45. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6
46. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells
47. Glomerular and dermal deposition of properdin in systemic lupus erythematosus
48. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita
49. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen
50. Immune-mediated subepithelial blistering diseases of mucous membranes
51. Lichen planus pemphigoides: Identification of 180 kD hemidesmosome antigen
52. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extra-cellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2